| Kari Beth Watts, DO | |
|
1000 Oakland Dr, Kalamazoo, MI 49008-1282 | |
| (269) 337-4400 | |
| Not Available |
| Full Name | Kari Beth Watts |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 1000 Oakland Dr, Kalamazoo, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043693831 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 125066896 (Illinois) | Secondary |
| 207Q00000X | Family Medicine | 5101026039 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bronson Methodist Hospital | Kalamazoo, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Western Michigan University School Of Medicine | 7517113954 | 67 |
News Archive
Though HIV prevalence in Nepal has dropped from 0.45 percent in 2005 to 0.3 percent in 2012, according to a new report (.pdf) from the government, "poor understanding of antiretroviral therapy (ART) amongst health officials, clinicians and patients in Nepal could undermine those gains ... and threaten future progress in lowering the number of new infections," PlusNews reports.
The Wake Forest Institute for Regenerative Medicine and Oracle Health Sciences have teamed as part of the Innovation Quarter's iQ Healthtech Labs to develop a consortium of industry, government, and academic members that will study novel approaches to establishing the safety of new drugs that are nearing clinical investigation in humans and FDA approval.
Scientists from the Florida campus of The Scripps Research Institute have uncovered the unique mechanism of a powerful natural product with wide-ranging antifungal, antibacterial, anti-malaria and anti-cancer effects.
Study findings based on observations from a sleep clinic in Brazil indicate that obstructive sleep apnea may worsen during the winter months.
Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients' treatments. The genome-based blood tests, believed to be the first of their kind, may be used to monitor tumor levels after therapy and determine cancer recurrence.
› Verified 8 days ago
| Entity Name | Bronson Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417961137 PECOS PAC ID: 0244148633 Enrollment ID: O20031208000832 |
News Archive
Though HIV prevalence in Nepal has dropped from 0.45 percent in 2005 to 0.3 percent in 2012, according to a new report (.pdf) from the government, "poor understanding of antiretroviral therapy (ART) amongst health officials, clinicians and patients in Nepal could undermine those gains ... and threaten future progress in lowering the number of new infections," PlusNews reports.
The Wake Forest Institute for Regenerative Medicine and Oracle Health Sciences have teamed as part of the Innovation Quarter's iQ Healthtech Labs to develop a consortium of industry, government, and academic members that will study novel approaches to establishing the safety of new drugs that are nearing clinical investigation in humans and FDA approval.
Scientists from the Florida campus of The Scripps Research Institute have uncovered the unique mechanism of a powerful natural product with wide-ranging antifungal, antibacterial, anti-malaria and anti-cancer effects.
Study findings based on observations from a sleep clinic in Brazil indicate that obstructive sleep apnea may worsen during the winter months.
Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients' treatments. The genome-based blood tests, believed to be the first of their kind, may be used to monitor tumor levels after therapy and determine cancer recurrence.
› Verified 8 days ago
| Entity Name | Grace Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518945278 PECOS PAC ID: 1052229226 Enrollment ID: O20040206000435 |
News Archive
Though HIV prevalence in Nepal has dropped from 0.45 percent in 2005 to 0.3 percent in 2012, according to a new report (.pdf) from the government, "poor understanding of antiretroviral therapy (ART) amongst health officials, clinicians and patients in Nepal could undermine those gains ... and threaten future progress in lowering the number of new infections," PlusNews reports.
The Wake Forest Institute for Regenerative Medicine and Oracle Health Sciences have teamed as part of the Innovation Quarter's iQ Healthtech Labs to develop a consortium of industry, government, and academic members that will study novel approaches to establishing the safety of new drugs that are nearing clinical investigation in humans and FDA approval.
Scientists from the Florida campus of The Scripps Research Institute have uncovered the unique mechanism of a powerful natural product with wide-ranging antifungal, antibacterial, anti-malaria and anti-cancer effects.
Study findings based on observations from a sleep clinic in Brazil indicate that obstructive sleep apnea may worsen during the winter months.
Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients' treatments. The genome-based blood tests, believed to be the first of their kind, may be used to monitor tumor levels after therapy and determine cancer recurrence.
› Verified 8 days ago
| Entity Name | Family Health Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811065576 PECOS PAC ID: 1759370216 Enrollment ID: O20040510000899 |
News Archive
Though HIV prevalence in Nepal has dropped from 0.45 percent in 2005 to 0.3 percent in 2012, according to a new report (.pdf) from the government, "poor understanding of antiretroviral therapy (ART) amongst health officials, clinicians and patients in Nepal could undermine those gains ... and threaten future progress in lowering the number of new infections," PlusNews reports.
The Wake Forest Institute for Regenerative Medicine and Oracle Health Sciences have teamed as part of the Innovation Quarter's iQ Healthtech Labs to develop a consortium of industry, government, and academic members that will study novel approaches to establishing the safety of new drugs that are nearing clinical investigation in humans and FDA approval.
Scientists from the Florida campus of The Scripps Research Institute have uncovered the unique mechanism of a powerful natural product with wide-ranging antifungal, antibacterial, anti-malaria and anti-cancer effects.
Study findings based on observations from a sleep clinic in Brazil indicate that obstructive sleep apnea may worsen during the winter months.
Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients' treatments. The genome-based blood tests, believed to be the first of their kind, may be used to monitor tumor levels after therapy and determine cancer recurrence.
› Verified 8 days ago
| Entity Name | Western Michigan University School Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316212343 PECOS PAC ID: 7517113954 Enrollment ID: O20120817000243 |
News Archive
Though HIV prevalence in Nepal has dropped from 0.45 percent in 2005 to 0.3 percent in 2012, according to a new report (.pdf) from the government, "poor understanding of antiretroviral therapy (ART) amongst health officials, clinicians and patients in Nepal could undermine those gains ... and threaten future progress in lowering the number of new infections," PlusNews reports.
The Wake Forest Institute for Regenerative Medicine and Oracle Health Sciences have teamed as part of the Innovation Quarter's iQ Healthtech Labs to develop a consortium of industry, government, and academic members that will study novel approaches to establishing the safety of new drugs that are nearing clinical investigation in humans and FDA approval.
Scientists from the Florida campus of The Scripps Research Institute have uncovered the unique mechanism of a powerful natural product with wide-ranging antifungal, antibacterial, anti-malaria and anti-cancer effects.
Study findings based on observations from a sleep clinic in Brazil indicate that obstructive sleep apnea may worsen during the winter months.
Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients' treatments. The genome-based blood tests, believed to be the first of their kind, may be used to monitor tumor levels after therapy and determine cancer recurrence.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kari Beth Watts, DO 815 Main St, Peoria, IL 61602-1076 Ph: () - | Kari Beth Watts, DO 1000 Oakland Dr, Kalamazoo, MI 49008-1282 Ph: (269) 337-4400 |
News Archive
Though HIV prevalence in Nepal has dropped from 0.45 percent in 2005 to 0.3 percent in 2012, according to a new report (.pdf) from the government, "poor understanding of antiretroviral therapy (ART) amongst health officials, clinicians and patients in Nepal could undermine those gains ... and threaten future progress in lowering the number of new infections," PlusNews reports.
The Wake Forest Institute for Regenerative Medicine and Oracle Health Sciences have teamed as part of the Innovation Quarter's iQ Healthtech Labs to develop a consortium of industry, government, and academic members that will study novel approaches to establishing the safety of new drugs that are nearing clinical investigation in humans and FDA approval.
Scientists from the Florida campus of The Scripps Research Institute have uncovered the unique mechanism of a powerful natural product with wide-ranging antifungal, antibacterial, anti-malaria and anti-cancer effects.
Study findings based on observations from a sleep clinic in Brazil indicate that obstructive sleep apnea may worsen during the winter months.
Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients' treatments. The genome-based blood tests, believed to be the first of their kind, may be used to monitor tumor levels after therapy and determine cancer recurrence.
› Verified 8 days ago
Dr. James Lewis Hunt, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1820 Shaffer St, Kalamazoo, MI 49048 Phone: 269-381-7136 Fax: 269-381-6665 | |
Gabriella Palmitessa, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6565 W Main St, Kalamazoo, MI 49009 Phone: 269-375-0400 Fax: 269-372-8484 | |
Katherine Alizo, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8088 Vineyard Pkwy, Kalamazoo, MI 49009 Phone: 269-286-7090 | |
Lauren Piper, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 117 W Paterson St, Kalamazoo, MI 49007 Phone: 269-349-2641 | |
Dr. Aydin Tavakoli, M.D., MSC, BSC Family Medicine Medicare: Medicare Enrolled Practice Location: 1000 Oakland Dr, Kalamazoo, MI 49008 Phone: 269-337-4400 | |
Dr. Alec Frederick Macdonald, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6938 Elm Valley Dr Ste 101, Kalamazoo, MI 49009 Phone: 269-552-4233 |